Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
NTLA - As of  05/14/24, 05:00:03 AM:   17 Insider Transactions.

Sector: Unknown    Industry: Unknown
Prev Close:$19.93  Avg Vol(3m): 418,220  P/E: 0.00  EPS: -69.20

Email this page to a friend.    Insider Transactions for NTLA

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
S 2020-08-20 16:30:13.0 Intellia Therapeutics NTLA Novartis Institutes for BioMedical Research 7.4% view
S 2020-02-14 11:43:08.0 Intellia Therapeutics NTLA ARK Investment Management LLC 3.46% view
B 2020-02-12 17:24:15.0 Intellia Therapeutics NTLA Nikko Asset Management Americas 7.2% view
S 2020-02-12 06:06:28.0 Intellia Therapeutics NTLA FMR LLC 0.324% view
B 2019-08-08 06:02:31.0 Intellia Therapeutics NTLA Sumitomo Mitsui Trust Holdings 14.09% view
B 2019-07-09 08:53:31.0 Intellia Therapeutics NTLA Nikko Asset Management Americas 2.05% view
S 2019-07-09 06:11:46.0 Intellia Therapeutics NTLA Caribou Biosciences 4.0% view
B 2019-02-14 11:32:40.0 Intellia Therapeutics NTLA STATE STREET CORP 5.3% view
S 2019-02-11 15:15:54.0 Intellia Therapeutics NTLA Atlas Venture Fund IX 3.72% view
S 2019-02-07 18:10:26.0 Intellia Therapeutics NTLA BlackRock Inc 5.8% view
S 2018-03-23 17:27:52.0 Intellia Therapeutics NTLA Novartis Institutes for BioMedical Research 4.99% view
S 2018-02-13 09:39:49.0 Intellia Therapeutics NTLA FMR LLC 8.45% view
B 2018-02-06 16:07:13.0 Intellia Therapeutics NTLA Caribou Biosciences 5.99% view
S 2017-12-14 12:29:18.0 Intellia Therapeutics NTLA ORBIMED ADVISORS LLC 5.99% view
B 2017-02-14 11:25:00.0 Intellia Therapeutics NTLA Atlas Venture Fund IX 12.3% view
B 2016-06-10 08:42:26.0 Intellia Therapeutics NTLA ORBIMED ADVISORS LLC 7.4% view
B 2016-05-11 16:09:42.0 Intellia Therapeutics n/a REGENERON PHARMACEUTICALS INC 15.48% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.